Strides Pharma Science (NSE:STAR) Inventory Turnover: 0.33 (As of Mar. 2026)

What is Strides Pharma Science Inventory Turnover?

Strides Pharma Science NSE:STAR +2.95% 67 Inventory Turnover is 0.33 as of Mar. 2026. GuruFocus rates NSE:STAR with a GF Score™ of 67/100 and a GF Value™ of ₹775.99 (Significantly Overvalued). The stock has 4 warning signs investors should review.

Inventory Turnover measures how fast the company turns over its inventory within a year. It is calculated as Cost of Goods Sold divided by Total Inventories. Strides Pharma Science's Cost of Goods Sold for the three months ended in Mar. 2026 was ₹5,362 Mil. Strides Pharma Science's Average Total Inventories for the quarter that ended in Mar. 2026 was ₹16,348 Mil. Strides Pharma Science's Inventory Turnover for the quarter that ended in Mar. 2026 was 0.33.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory. Strides Pharma Science's Days Inventory for the three months ended in Mar. 2026 was 278.18.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Strides Pharma Science's Inventory-to-Revenue for the quarter that ended in Mar. 2026 was 1.24.

Strides Pharma Science (NSE:STAR) Inventory Turnover Explanation

Inventory Turnover measures how fast the company turns over its inventory within a year. A higher Inventory Turnover means the company has light inventory. Therefore the company spends less money on storage, write downs, and obsolete inventory. If the inventory is too light, it may affect sales because the company may not have enough to meet demand.

1. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Strides Pharma Science's Days Inventory for the three months ended in Mar. 2026 is calculated as:

Days Inventory	=	Average Total Inventories (Q: Mar. 2026 )	/	Cost of Goods Sold (Q: Mar. 2026 )	*	Days in Period
	=	16347.94	/	5362.45	*	365 / 4
	=	278.18

2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Strides Pharma Science's Inventory to Revenue for the quarter that ended in Mar. 2026 is calculated as

Inventory-to-Revenue	=	Average Total Inventories (Q: Mar. 2026 )	/	Revenue (Q: Mar. 2026 )
	=	16347.94	/	13234.7
	=	1.24

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Be Aware

Usually retailers pile up their inventories at holiday seasons to meet the stronger demand. Therefore, the inventory of a particular quarter of a year should not be used to calculate Inventory Turnover. An average inventory is a better indication.

Strides Pharma Science Inventory Turnover Related Terms

Strides Pharma Science Inventory Turnover Historical Data

* Premium members only.

The historical data trend for Strides Pharma Science's Inventory Turnover can be seen below:

Strides Pharma Science Inventory Turnover Chart

Strides Pharma Science Annual Data

Trend

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Mar25

Mar26

Inventory Turnover

Get a 7-Day Free Trial

1.37

1.50

1.66

1.65

1.35

Strides Pharma Science Quarterly Data
	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25	Jun25	Sep25	Dec25	Mar26
Inventory Turnover	Get a 7-Day Free Trial															0.39	0.35	0.35	0.32	0.33

67GF Score

Strides Pharma Science Ltd NSE:STAR

Inventory Turnover is just one metric. See GF Score™, valuation, warning signs, and more.

View Full Analysis

Strides Pharma Science Inventory Turnover Calculation

Strides Pharma Science's Inventory Turnover for the fiscal year that ended in Mar. 2026 is calculated as

	Inventory Turnover (A: Mar. 2026 )
=	Cost of Goods Sold	/	Average Total Inventories
=	Cost of Goods Sold (A: Mar. 2026 )	/ (	(Total Inventories (A: Mar. 2025 )	+	Total Inventories (A: Mar. 2026 ))	/	count )
=	19587.3	/ (	(12775.71	+	16347.94)	/	2 )
=	19587.3	/	14561.825
=	1.35

Strides Pharma Science's Inventory Turnover for the quarter that ended in Mar. 2026 is calculated as

	Inventory Turnover (Q: Mar. 2026 )
=	Cost of Goods Sold	/	Average Total Inventories
=	Cost of Goods Sold (Q: Mar. 2026 )	/ (	(Total Inventories (Q: Dec. 2025 )	+	Total Inventories (Q: Mar. 2026 ))	/	count )
=	5362.45	/ (	(0	+	16347.94)	/	1 )
=	5362.45	/	16347.94
=	0.33

Frequently Asked Questions Learn more about Inventory Turnover →

What does a Inventory Turnover of 0.33 mean?

Strides Pharma Science (NSE:STAR) has a Inventory Turnover of 0.33 as of Mar. 2026. Inventory turnover equals current-period cost of goods sold divided by average two-period total inventories. View historical data on Strides Pharma Science and its competitors.

Is Strides Pharma Science's Inventory Turnover too high?

Strides Pharma Science's current Inventory Turnover is 0.33. Overall, Strides Pharma Science has a GF Score™ of 67/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.

How does Strides Pharma Science's Inventory Turnover compare to ZTS and UTHR?

Strides Pharma Science's Inventory Turnover of 0.33 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good Inventory Turnover for a Drug Manufacturers company?

A good Inventory Turnover depends on the Drug Manufacturers industry context. However, Inventory Turnover should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high Inventory Turnover mean?

A high Inventory Turnover can signal that a stock is expensive relative to its fundamentals. Inventory turnover equals current-period cost of goods sold divided by average two-period total inventories. View historical data on Strides Pharma Science and its competitors. Strides Pharma Science's current Inventory Turnover is 0.33. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is Strides Pharma Science stock overvalued right now?

Based on GuruFocus' analysis, Strides Pharma Science (NSE:STAR) is currently considered Significantly Overvalued. The stock's GF Value™ is ₹775.99, compared to a current price of ₹1,126.40 — trading 45.2% above its estimated fair value. The current Inventory Turnover is 0.33. Strides Pharma Science's overall GF Score™ is 67/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is Inventory Turnover calculated?

Inventory Turnover is calculated from a company's financial statements. For Strides Pharma Science (NSE:STAR), the current Inventory Turnover is 0.33 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Strides Pharma Science (NSE:STAR) Overvalued in 2026?

Based on GuruFocus' analysis, Strides Pharma Science stock appears to be overvalued. The current stock price of ₹1,126.40 is trading 45.2% above its estimated GF Value™ of ₹775.99. GuruFocus considers Strides Pharma Science to be Significantly Overvalued.

Key valuation signals for NSE:STAR:

Inventory Turnover: 0.33
GF Value™: ₹775.99 vs. price of ₹1,126.40 (45.2% above fair value)
GF Score™: 67/100 with 4 warning signs

No single metric tells the full story. See the NSE:STAR stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Strides Pharma Science Business Description

Industry Healthcare Drug Manufacturers

Comparable Companies BOM:500126 BOM:544222 BOM:544619 BOM:530549 BOM:512529 BOM:532872 BOM:530239 BOM:531599 BOM:543322 BOM:543748 XTER:MRK XSWX:GALD TSE:4502 SHSE:600276 NSE:SUNPHARMA LSE:HLN XTAE:TEVA XSWX:SDZ ZTS UTHR

Other Exchanges 532531:India

Address Bannerghatta Road, Strides House, Bilekahalli, Bengaluru, KA, IND, 560076

Website https://www.strides.com

Strides Pharma Science Ltd develops and manufactures a wide range of IP-led niche pharmaceutical products. Its diverse portfolio spans complex generics across multiple dosage forms, including tablets, hard capsules, sachets, liquids, nasal sprays, topicals, and controlled substances. It also manufactures drugs in the anti-retroviral, anti-malarial, anti-tuberculosis, Hepatitis, and other infectious disease drug segments for its institutional business. The customers for this business include institutionally funded aid projects and procurement agencies. With its R&D, integration, and distribution network, the company brings differentiated products to market across the U.S., Australia, Europe, Africa, and Emerging Markets. Geographically, it generates maximum revenue from North America.

67GF Score

Get the complete analysis for NSE:STAR

Inventory Turnover is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹1,126.40

Price

₹775.99

GF Value

View NSE:STAR Analysis

See Inventory Turnover data for all stocks →